Press Releases
nLife Therapeutics receives USD 350,000 from The Michael J. Fox Foundation for Parkinson’s Research
nLife Therapeutics, an early-stage biopharmaceutical company leading developments in nOligos (neuronal specific oligonucleotides) as therapeutic agents for CNS disorders, today announces that The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has awarded the company a grant of USD...
Press Releases
Domain Therapeutics appoints Professor Michel Bouvier as chairman of the Scientific Advisory Board
Domain Therapeutics, a biopharmaceutical company specializing in the research and development of new medicines targeting G protein-coupled receptors (GPCRs), today announces the nomination of Michel Bouvier as chairman of the company’s Scientific Advisory Board. Michel Bouvier,...
Press Releases
CleveXel Pharma partners with Guilin Pharmaceutical to develop two new anti-malarial products
CleveXel Pharma today announces that the company has entered into a new partnering agreement with Guilin Pharmaceutical, a Chinese company located in Shanghai, regarding the development of two new products. Guilin Pharmaceutical, a member of Fosun...
Press Releases
Pharmacy Times Reveals Pharmacists’ OTC Favorites
The 2014 OTC Guide supplement issue, website, and mobile app, touted on the TODAY show, announce the most recommended OTC products in more than 150 categories. The collective recommendations of thousands of pharmacists were revealed on...
Press Releases
Astellas Details Pipeline Progress at R&D Meeting
Astellas today announced progress on the Company's efforts to reshape its research framework at its R&D meeting held in Tokyo on July 10. The meeting provided an opportunity for Astellas to present a comprehensive overview of its late-stage clinical...
Press Releases
Weight-Loss Surgery, Prescriptions More Satisfying for Obese Patients
Obese patients who underwent surgery or took medications to lose weight were more satisfied with their results than those who made lifestyle changes.
Nearly 60% of obese patients are not taking any action to lose weight, according to the results...
Press Releases
Japan Approves- Oral, Interferon and Ribavirin Free Hepatitis C Treatment and others
Offers new treatment option for genotype 1 HCV patients in Japan who are interferon-ineligible/intolerant, or did not previously respond to treatment Japanese HCV patients in urgent need of care now have opportunity for cure, including older patients and those...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read